Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.99
-0.3148-0.76%
Post-market: 40.990.00000.00%16:10 EDT
Volume:44.88K
Turnover:1.84M
Market Cap:204.13M
PE:- -
High:41.42
Open:41.36
Low:40.84
Close:41.30
52wk High:47.00
52wk Low:29.28
Shares:4.98M
Float Shares:4.98M
Volume Ratio:1.33
T/O Rate:0.90%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Coursera, PSEG, Nauticus, Legend, Arlo Insider Shock

TIPRANKS
·
Yesterday

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Yesterday

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Yesterday

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
Yesterday

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
Yesterday

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS
·
Yesterday

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

TIPRANKS
·
Oct 02

Correction: Top Midday Decliners

MT Newswires Live
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Enliven initiated with an Overweight at Morgan Stanley

TIPRANKS
·
Oct 02

Legend Biotech Director Makes Bold Move With Fresh Insider Stock Sale

TIPRANKS
·
Oct 02

Revolution Medicines Chief Development Officer Alan B. Sandler Disposes of USD 1,264,082 in Common Shares

Reuters
·
Oct 02

Legend Biotech Director Corazon D. Sanders Sells 27,370 Shares for $258,920.20

Reuters
·
Oct 02

Sector Update: Healthcare

MT Newswires Live
·
Oct 02

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

Reuters
·
Oct 02

Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says

MT Newswires Live
·
Oct 02

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

TIPRANKS
·
Oct 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 01

Legend Biotech Launches Inaugural Elite Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

THOMSON REUTERS
·
Oct 01